Table 4.
Cardiac magnetic resonance imaging
| Study inclusion (n=14) | 12 months after study start (n=14) | P-value | |
|---|---|---|---|
| LVEF (%) | 53 (33; 69) | 54 (28; 71) | ns |
| EDV (mL) | 161 (87; 278) | 162 (102; 289) | ns |
| ESV (mL) | 69 (40; 185) | 76 (40; 207) | ns |
| LV myocardial mass (g) | 196 (100; 247) | 180 (85; 237) | 0.03 |
| MAPSE (mm) | 7 (3; 10) | 6 (3; 9) | ns |
| TAPSE (mm) | 12 (4; 17) | 11 (5; 16) | ns |
Note: Continuous data are expressed as median (range).
Abbreviations: EDV, end-diastolic volume; ESV, end-systolic volume; LVEF, left ventricular ejection fraction; MAPSE, mitral annular plane systolic excursion; ns, nonsignificant; TAPSE, tricuspid annular plane systolic excursion.